This article has been updated to include Decode's closing stock price on Thursday.
 
NEW YORK (GenomeWeb News) – Decode Genetics said after the close of the market on Wednesday that it is conducting a review of its long-term business strategy with a goal of sharpening its business focus and selling non-core assets, among other aims.
 
Decode's shares tumbled 34 percent to close at $.25 in Thursday trade on the Nasdaq. Its shares are down more than 90 percent from the beginning of the year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.